Mark Albertini practices Oncology. He studied medicine at University of Vermont College of Medicine. He received 2 awards: "America's Top Doctors" and "America's Top Doctors for Cancer". Mark Albertini is a published doctor. He has 17 publications published. The most current publication "A phase I study to determine the maximum tolerated dose and safety of oral LR-103 (1,24(S)Dihydroxyvitamin D2) in patients with advanced cancer." Doctor Mark R. Albertini, MD accepts Medicare payments and is registered with Medicare.gov.
|
Dr. Robert B. Hegeman, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Daniel L. Mulkerin, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Michael S. Frontiera, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Amye J. Tevaarwerk, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Justine Y. Bruce, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Howard H. Bailey, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Jeremy P. Cetnar, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. George Wilding, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. David L. Hei, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. James F. Cleary, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Tien Hoang, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Alissa A. Weber, MD
This Doctor is OpenDoctor Recommended.
|